Wire · opportunities
Blood-based circular RNAs emerge as a breakthrough early diagnostic tool for Alzheimer's disease
◆ Sectors
BiotechDiagnostics
◆ Source
◆ Verified
Fusion42 · 22 August 2026 · Fusion42 review
Researchers have identified blood-based circular RNAs as a breakthrough tool for early diagnosis of Alzheimer's disease, offering a minimally invasive method to detect the condition earlier than current techniques.
This Wire brief sits within Fusion42's coverage of Biotech and Diagnostics.
◆ ◆ The Wire takeaway
You can now explore blood-based RNA tests to catch Alzheimer's earlier than before, creating a new diagnostic approach that could reshape market demand and clinical trials.
◆ Coverage
1 source · 22 Aug 2026
◆ Related on Wire
◆ Topics
BiotechDiagnosticsalzheimerscircular-rnaearly-diagnosisbiotechdiagnostics